Aaron P. Jansen, Ph.D. - Publications
Affiliations: | 2000 | University of Wisconsin, Madison, Madison, WI |
Area:
Oncology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2008 | Schmid T, Jansen AP, Baker AR, Hegamyer G, Hagan JP, Colburn NH. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Research. 68: 1254-60. PMID 18296647 DOI: 10.1158/0008-5472.CAN-07-1719 | 0.376 | |||
2005 | Jansen AP, Camalier CE, Colburn NH. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Research. 65: 6034-41. PMID 16024603 DOI: 10.1158/0008-5472.CAN-04-2119 | 0.461 | |||
2001 | Jansen AP, Dreckschmidt NE, Verwiebe EG, Wheeler DL, Oberley TD, Verma AK. Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C alpha, -delta and -epsilon transgenic mice. International Journal of Cancer. 93: 635-43. PMID 11477572 DOI: 10.1002/Ijc.1395 | 0.522 | |||
2001 | Yang HS, Jansen AP, Nair R, Shibahara K, Verma AK, Cmarik JL, Colburn NH. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene. 20: 669-76. PMID 11314000 DOI: 10.1038/Sj.Onc.1204137 | 0.527 | |||
2001 | Jansen AP, Verwiebe EG, Dreckschmidt NE, Wheeler DL, Oberley TD, Verma AK. Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma. Cancer Research. 61: 808-12. PMID 11221859 | 0.535 | |||
1999 | Jansen AP, Colburn NH, Verma AK. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation. Oncogene. 18: 5806-13. PMID 10523861 DOI: 10.1038/Sj.Onc.1202965 | 0.558 | |||
Show low-probability matches. |